Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial

Stephen E. Goldstone*, Anna R. Giuliano, Joel M. Palefsky, Eduardo Lazcano-Ponce, Mary E. Penny, Robinson E. Cabello, Edson D. Moreira, Ezio Baraldi, Heiko Jessen, Alex Ferenczy, Robert Kurman, Brigitte M. Ronnett, Mark H. Stoler, Oliver Bautista, Rituparna Das, Thomas Group, Alain Luxembourg, Hao Jin Zhou, Alfred Saah

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

62 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial'. Together they form a unique fingerprint.

Medicine and Dentistry